Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)

Shanghai ZJ Bio-Tech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2,308	2,553	2,783	2,769	3,148	2,936
Trading Asset Securities	449.4	347.89	-	-	-	-
Cash & Short-Term Investments	2,758	2,901	2,783	2,769	3,148	2,936
Cash Growth	-2.03%	4.21%	0.50%	-12.02%	7.21%	143.70%
Accounts Receivable	32.86	31.79	55.27	102.1	227.63	218.39
Other Receivables	0.9	0.59	22.78	25.05	9.45	75.76
Receivables	33.76	32.38	78.05	127.15	237.08	294.15
Inventory	36.91	45.57	57.37	253.6	504.03	299.47
Other Current Assets	14.83	7.62	16.8	15.79	21.01	23.3
Total Current Assets	2,843	2,986	2,936	3,166	3,910	3,553
Property, Plant & Equipment	592.54	628.22	680.95	743.91	661.63	562.36
Long-Term Investments	71.23	64.93	95.46	101.05	113.46	74.97
Goodwill	5.4	5.4	5.4	5.4	5.4	5.4
Other Intangible Assets	26.76	7.04	7.8	6.06	6.84	6.57
Long-Term Deferred Tax Assets	67.4	68.81	60.8	37.16	9.46	7.44
Long-Term Deferred Charges	2.72	3.2	3.82	2.86	3.66	-
Other Long-Term Assets	-	-	0.11	11.71	33.55	45.1
Total Assets	3,609	3,764	3,790	4,074	4,744	4,255

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	48.07	38.16	78.75	120.58	317.67	236.95
Accrued Expenses	34.52	60.47	43.67	74.03	99.78	75.92
Current Portion of Long-Term Debt	11.52	9.93	-	-	-	-
Current Portion of Leases	-	1.82	1.73	2.81	2.94	-
Current Income Taxes Payable	3.41	0.06	0.09	0.01	26.82	32.28
Current Unearned Revenue	7.31	9	15.28	24.02	59.32	55.29
Other Current Liabilities	4.9	7.15	6.46	15.12	17.33	8.56
Total Current Liabilities	109.72	126.58	145.99	236.56	523.86	409
Long-Term Debt	277.16	284.26	-	-	-	-
Long-Term Leases	2.04	2.96	3.19	4.64	5.69	-
Long-Term Unearned Revenue	0.92	1.14	3.88	7.59	11.71	13.74
Long-Term Deferred Tax Liabilities	-	-	-	0.45	2.17	4.54
Total Liabilities	389.83	414.95	153.06	249.25	543.44	427.27

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	189.84	192.16	192.16	194.7	194.7	194.7
Additional Paid-In Capital	2,018	2,051	2,051	2,150	2,150	2,150
Retained Earnings	1,352	1,410	1,438	1,587	1,953	1,458
Treasury Stock	-325.38	-294.44	-35.33	-102.03	-102.03	-
Comprehensive Income & Other	-14.99	-9.87	-8.88	-4.51	4.73	24.35
Total Common Equity	3,219	3,349	3,637	3,825	4,200	3,827
Shareholders' Equity	3,219	3,349	3,637	3,825	4,200	3,827
Total Liabilities & Equity	3,609	3,764	3,790	4,074	4,744	4,255

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	290.71	298.97	4.93	7.45	8.63	-
Net Cash (Debt)	2,467	2,602	2,778	2,762	3,139	2,936
Net Cash Growth	-5.63%	-6.36%	0.60%	-12.01%	6.92%	143.70%
Net Cash Per Share	14.41	14.41	14.60	14.33	16.23	15.40
Filing Date Shares Outstanding	160.48	175.71	189.84	192.16	192.16	194.7
Total Common Shares Outstanding	160.48	175.71	189.84	192.16	192.16	194.7
Working Capital	2,733	2,860	2,790	2,929	3,386	3,144
Book Value Per Share	20.06	19.06	19.16	19.91	21.86	19.66
Tangible Book Value	3,187	3,336	3,624	3,813	4,188	3,815
Tangible Book Value Per Share	19.86	18.99	19.09	19.85	21.80	19.60
Buildings	-	772.93	770.99	757.66	639.77	547.36
Machinery	-	160.52	156.51	208.32	194.57	145.72
Construction In Progress	-	0.03	0.34	2.12	1.18	0.98

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error